[go: up one dir, main page]

BR9200430A - Aplicacao de uma combinacao de um diuretico de alca e de um medicamento anti-inflamatorio nao esteroide e a dita combinacao - Google Patents

Aplicacao de uma combinacao de um diuretico de alca e de um medicamento anti-inflamatorio nao esteroide e a dita combinacao

Info

Publication number
BR9200430A
BR9200430A BR929200430A BR9200430A BR9200430A BR 9200430 A BR9200430 A BR 9200430A BR 929200430 A BR929200430 A BR 929200430A BR 9200430 A BR9200430 A BR 9200430A BR 9200430 A BR9200430 A BR 9200430A
Authority
BR
Brazil
Prior art keywords
combination
alta
diuretic
application
steroid anti
Prior art date
Application number
BR929200430A
Other languages
English (en)
Inventor
Sebastiano Bianco
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9200430A publication Critical patent/BR9200430A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR929200430A 1991-02-09 1992-02-07 Aplicacao de uma combinacao de um diuretico de alca e de um medicamento anti-inflamatorio nao esteroide e a dita combinacao BR9200430A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91101817 1991-02-09

Publications (1)

Publication Number Publication Date
BR9200430A true BR9200430A (pt) 1992-10-13

Family

ID=8206392

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929200430A BR9200430A (pt) 1991-02-09 1992-02-07 Aplicacao de uma combinacao de um diuretico de alca e de um medicamento anti-inflamatorio nao esteroide e a dita combinacao

Country Status (15)

Country Link
US (2) US5366967A (pt)
EP (1) EP0499142A3 (pt)
JP (1) JPH0680587A (pt)
KR (1) KR920016093A (pt)
AU (1) AU652798B2 (pt)
BR (1) BR9200430A (pt)
CA (1) CA2060954A1 (pt)
CS (1) CS35392A3 (pt)
HU (1) HU209609B (pt)
IE (1) IE920426A1 (pt)
IL (1) IL100897A0 (pt)
MX (1) MX9200570A (pt)
NO (1) NO920503L (pt)
NZ (1) NZ241541A (pt)
ZA (1) ZA92891B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499143B1 (en) * 1991-02-09 1999-05-06 B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. Anti-reactive anti-asthmatic activity of acetylsalicylic acid by inhalation
JPH11503352A (ja) 1995-04-14 1999-03-26 グラクソ、ウェルカム、インコーポレーテッド プロピオン酸フルチカゾン用計量投与用吸入器
NZ306281A (en) 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
AU718263B2 (en) 1995-04-14 2000-04-13 Smithkline Beecham Corporation Metered dose inhaler for salmeterol
AU710382B2 (en) 1995-04-14 1999-09-16 Glaxo Wellcome Inc. Metered dose inhaler for albuterol
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
US7028990B2 (en) * 2001-05-11 2006-04-18 Ray Robert Shorey Temporary rooftop and stairway safety rail system
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US10149823B2 (en) 2013-04-30 2018-12-11 Otitopic Inc. Dry powder formulations and methods of use
CN112656780A (zh) 2014-02-20 2021-04-16 奥迪托皮克股份有限公司 用于吸入的干粉制剂
US10758537B2 (en) * 2015-09-30 2020-09-01 Rutgers, The State University Of New Jersey Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
DE4010536A1 (de) * 1990-04-02 1991-10-10 Boehringer Mannheim Gmbh Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure

Also Published As

Publication number Publication date
CS35392A3 (en) 1992-08-12
EP0499142A2 (en) 1992-08-19
JPH0680587A (ja) 1994-03-22
US5750559A (en) 1998-05-12
MX9200570A (es) 1994-07-29
HU209609B (en) 1994-09-28
EP0499142A3 (en) 1993-05-05
IL100897A0 (en) 1992-11-15
US5366967A (en) 1994-11-22
AU652798B2 (en) 1994-09-08
NO920503D0 (no) 1992-02-07
CA2060954A1 (en) 1992-08-10
AU1077092A (en) 1992-08-13
KR920016093A (ko) 1992-09-24
NZ241541A (en) 1996-05-28
HU9200390D0 (en) 1992-04-28
ZA92891B (en) 1992-12-30
IE920426A1 (en) 1992-08-12
NO920503L (no) 1992-08-10
HUT60438A (en) 1992-09-28

Similar Documents

Publication Publication Date Title
BR9200430A (pt) Aplicacao de uma combinacao de um diuretico de alca e de um medicamento anti-inflamatorio nao esteroide e a dita combinacao
DE69226084D1 (de) Hochspannungskondensator und magnetron
FI941921A0 (fi) Useamman päällystekerroksen mittaus ja säätö
FI935386L (fi) Roentgenkontrastmedel
BR8903107A (pt) Capacitor multiplaca e arranjo de componentes eletronicos
EP0695194A4 (en) IMPROVED DETECTION AND THERAPY OF LESIONS USING BIOTIN-AVIDIN CONJUGATES AND POLYMERS
DE69408190D1 (de) Bildsensor und elektronische Stehbildkamera
NO175801C (no) Gjentatt formbart flerlags fottöy og anvendelse av et slikt fottöy
FI901551A7 (fi) Infektioiden ja tulehdusten toteaminen ja hoito
DE69325283D1 (de) Formbarer reflektierender multischichtenkörper
MX9100447A (es) Reduccion y prevencion de sensibilizacion a drogas
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
ATE208618T1 (de) Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
NO306931B1 (no) Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel
DE69323599D1 (de) Kondensator mit metallisiertem Polyesterfilm
DE59205018D1 (de) Medizinische Leuchte
DK341589A (da) Amidino- og guanidinoderivater
DE69317789D1 (de) Pflaster mit einem vorrat an medizinisch aktiver substanz
FI900353A7 (fi) Pyrrolidiiniyhdiste ja sen farmaseuttinen käyttö
BR9106215A (pt) Processo para a determinacao de uma grandeza de medicao e uma instalacao de medicao
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
BR9106582A (pt) Derivados de tetrazol e medicamentos
NO933451D0 (no) Ekstruder for dosering av kunststoff eller kunststoffblandinger
FI900941A7 (fi) Atsasyklo-oktadiiniyhdiste ja sen farmaseuttinen käyttö
DE59205713D1 (de) Elektronische analognebenuhr mit zeigerlängen zwischen 250 und 600 mm

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 31/405; A61K 31/615; A61K 31/62; A61K 31/60.

Ipc: A61K 9/00 (2006.01), A61K 31/60 (2006.01), A61K 31

Ipc: A61K 9/00 (2006.01), A61K 31/60 (2006.01), A61K 31